Lonza Group: Strong CDMO demand, margin focus, and disciplined M&A drive growth amid tightening capacity
CDMO demand remains robust, with strategic focus shifting to pure-play operations and disciplined M&A. Specialized Modalities rebounded in 2026, while Integrated Biologics growth aligns with capacity cycles. Margin and free cash flow improvements are prioritized, and industry supply-demand is expec…
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.